cbdMD (AMEX:YCBD) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 97.73 percent increase over losses of $(1.76) per share from the same period last year. The company reported quarterly sales of $5.017 million which beat the analyst consensus estimate of $4.858 million by 3.27 percent. This is a 1.88 percent decrease over sales of $5.113 million the same period last year.